214 related articles for article (PubMed ID: 20729102)
41. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
42. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
Hadi R; Saunders V; Utkina O; Clingan P; Kam P; Links M; Morris DL
ANZ J Surg; 2006 Mar; 76(3):156-61. PubMed ID: 16626358
[TBL] [Abstract][Full Text] [Related]
43. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Iavazzo C; Spiliotis J
Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
[No Abstract] [Full Text] [Related]
44. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
Zoetmulder FA; van der Vange N; Witkamp AJ; Kaag MM; Boot H; Beijnen JH
Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1863-8. PubMed ID: 10526600
[TBL] [Abstract][Full Text] [Related]
45. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Sugarbaker PH
J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
[No Abstract] [Full Text] [Related]
46. [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
Deraco M; Kusamura S; Gronchi A
Tumori; 2003; 89(4 Suppl):54-5. PubMed ID: 12903545
[TBL] [Abstract][Full Text] [Related]
47. Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.
Wheeler BR; Reddy SK; Kenwright D; Keating JP
N Z Med J; 2014 Feb; 127(1389):31-9. PubMed ID: 24548955
[TBL] [Abstract][Full Text] [Related]
48. Pseudomyxoma peritonei.
Witham G
Nurs Times; 2003 Sep 30-Oct 6; 99(39):30-2. PubMed ID: 14562659
[TBL] [Abstract][Full Text] [Related]
49. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Tumori; 2001; 87(4):S3-5. PubMed ID: 11693816
[No Abstract] [Full Text] [Related]
50. [Updated treatment of peritoneal carcinomas: a review].
Deraco M; Laterza B; Kusamura S; Baratti D
Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
[TBL] [Abstract][Full Text] [Related]
51. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
52. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications.
Smeenk RM; Bex A; Verwaal VJ; Horenblas S; Zoetmulder FA
J Surg Oncol; 2006 Jan; 93(1):20-3. PubMed ID: 16353186
[TBL] [Abstract][Full Text] [Related]
53. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
[TBL] [Abstract][Full Text] [Related]
54. Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
Alves S; Mohamed F; Yadegarfar G; Youssef H; Moran BJ
Eur J Surg Oncol; 2010 Dec; 36(12):1156-61. PubMed ID: 20864306
[TBL] [Abstract][Full Text] [Related]
55. Peritoneal surface malignancies and regional treatment: a review of the literature.
Rubino MS; Abdel-Misih RZ; Bennett JJ; Petrelli NJ
Surg Oncol; 2012 Jun; 21(2):87-94. PubMed ID: 21216590
[TBL] [Abstract][Full Text] [Related]
56. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
57. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate.
Chua TC; Liauw W; Zhao J; Morris DL
Ann Surg; 2011 Apr; 253(4):769-73. PubMed ID: 21475018
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Scuderi S; Costamagna D; Vaira M; Barone R; De Simone M
Tumori; 2003; 89(4 Suppl):43-5. PubMed ID: 12903542
[TBL] [Abstract][Full Text] [Related]
59. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome.
Chua TC; Liauw W; Morris DL
Int J Colorectal Dis; 2012 Mar; 27(3):381-9. PubMed ID: 21853235
[TBL] [Abstract][Full Text] [Related]
60. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Yan TD; Bijelic L; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
